This year on World Heart Day (September 29th), the World Heart Federation is asking for a simple promise: Eat more healthily, get more active, and say no to smoking. But as you know, it’s vitally important to recognize every day, not just on World Heart Day, that cardiovascular disease (CVD) isn’t simple, and is the world’s number one killer: over 17 million people die of cardiovascular disease every year. What many people don’t realize as they go about their day-to-day lives is that this disease is in fact 80% preventable. That’s right—80%! (more…)
Syphilis: From Near-Eradication to Resurgence
When it comes to syphilis, most everyone has the same first thought: Wait, didn’t we solve that a while ago?
Syphilis was almost eradicated in the U.S., but is now on the rise – and it’s reaching 20 year highs.
Europe has also seen a resurgence of syphilis. According to the European Centre for Disease Prevention and Control: “With the widespread use of penicillin, syphilis prevalence had significantly declined after World War II. However, in several industrialised countries a considerable resurgence occurred in the late 1980s.” In fact, the UK has recently reported ‘a 12% increase relative to the year prior and the largest number of diagnoses reported since 1949’ (more…)
Discontinuation of Abbott’s MTX Assay Creates Urgent Need in Labs
Due to the importance of measuring Methotrexate (MTX) in patient healthcare, Abbott’s recent discontinuation of the TDx and TDxFLx FPIA Methotrexate assay has left many laboratories actively – and urgently – seeking an alternate testing option.
Why Run Methotrexate Tests in Your Laboratory?
While MTX is used to treat a wide range of conditions – from psoriasis to rheumatoid arthritis to a number of different forms of leukemia and cancer – it also possesses high toxicity. Because of this, patients undergoing MTX therapy for cancer must be closely monitored for early detection of any toxic effects. (more…)
Did you know you have the ability to unlock your instruments potential and add assays that are not offered by your instrument manufacturer? This open channel capability allows you to expand your test menu beyond your instrument manufacturers menu. This added benefit allows laboratories to enhance their test menu offerings by bringing in higher volume send out and niche testing. (more…)
In the field of clinical chemistry, most manufacture instruments are intended for use with the manufacturer’s specific packaged and barcoded reagents. This is often referred to as a ‘closed’ system.
What some labs are not aware of is that their chemistry analyzer may not be a fully ‘closed’ system.
Why does it matter if your system is closed or open?
If your system is not a closed analyzer, it opens up the option for your lab to use ‘pour over’ reagents. This means you have the option to utilize open channels on the instrument to expand the menu for tests that the manufacturer doesn’t offer. (more…)
Welcome to Dx Dialogue, where we’ll be sharing news, product information, as well as Point-of-Care testing, clinical chemistry, coagulation and enzymes product insights and more!
For those of you visiting Sekisui Diagnostics for the first time, we are a diverse company with broad product lines, a global sales and distribution network, extensive product development capabilities, state of the art global manufacturing facilities and deep diagnostics expertise. Our products and global presence are long-standing and significant, with more than 1.7 billion tests performed each year using our clinical chemistry products.
We invite you to follow Sekisui Diagnostics on our social platforms, including:
Finally – since Dx Dialogue is focused on providing you with the information you need – we welcome your topic suggestions and questions. Reach us by email here.